FinscoFinsco

Elevance Health (US.ELV)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.ELV · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion91.6%↑
ROE7.2%↓
Cash Conversion193.5%↑
D/E Ratio0.69→
Gross Margin0.0%↓
US.ELV (Elevance Health) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion    91.6%    ↑
ROE                7.2%    ↓
Cash Conversion  193.5%    ↑
D/E Ratio          0.69    →
Gross Margin       0.0%    ↓
Key Metrics
US.ELV (Elevance Health) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 91.6% ↑
ROE 7.2% ↓
Cash Conversion 193.5% ↑
D/E Ratio 0.69 →
Gross Margin 0.0% ↓

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies